Literature DB >> 11226628

Day/night variations of dopamine ocular content during Xenopus laevis ontogeny.

M J Delgado1, M V Céspedes, N De Pedro, M Alonso-Bedate, A L Alonso-Gómez.   

Abstract

Concentration of dopamine (DA) and its metabolite, 3,4-dihydroxyphenylacetic acid is quantified by high-pressure liquid chromatography with a coulometric detection system in the eye of Xenopus laevis through ontogeny and in adults at two times during photocycle (midday and midnight). Ocular dopaminergic activity remains low during pre- and prometamorphosis and significantly rises in postmetamorphic froglets. This increase is more pronounced at midnight than at midday. The dualism of DA content versus DA release in Xenopus ocular tissue is studied in an eyecup culture system. On a 24-h cycle of DA release from adult Xenopus eyecups the highest DA release by eyecups is produced during daytime, and significantly decreases in darkness. From these results it can be concluded that in spite of the early development of the retinal dopaminergic system in the ontogeny of Xenopus, the final maturation must occur during the metamorphic climax. Endogenous DA release is significantly inhibited by light offset, which explains the higher ocular DA content found at midnight as compared to midday in postmetamorphic froglets and adults.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11226628     DOI: 10.1016/s0304-3940(01)01560-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  Dopamine induces optical changes in the cichlid fish lens.

Authors:  J Marcus Schartau; Ronald H H Kröger; Bodil Sjögreen
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

2.  Metabolomic approach for identifying and visualizing molecular tissue markers in tadpoles of Xenopus tropicalis by mass spectrometry imaging.

Authors:  Naoko Goto-Inoue; Akihiko Kashiwagi; Keiko Kashiwagi; Tsukasa Mori
Journal:  Biol Open       Date:  2016-09-15       Impact factor: 2.422

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.